Larimar Therapeutics, Inc. (LRMR)
NASDAQ: LRMR · Real-Time Price · USD
3.660
+0.160 (4.57%)
At close: Jun 26, 2026, 4:00 PM EDT
4.000
+0.340 (9.29%)
After-hours: Jun 26, 2026, 7:59 PM EDT
Larimar Therapeutics Employees
Larimar Therapeutics had 71 employees as of December 31, 2025. The number of employees increased by 6 or 9.23% compared to the previous year.
Employees
71
Change (1Y)
6
Growth (1Y)
9.23%
Revenue / Employee
n/a
Profits / Employee
-$2,338,099
Market Cap
382.04M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Vanda Pharmaceuticals | 533 |
| Adlai Nortye | 109 |
| OmniAb | 89 |
| Upstream Bio | 75 |
| Lexeo Therapeutics | 59 |
| Atea Pharmaceuticals | 55 |
| Cybin | 50 |
| X4 Pharmaceuticals | 45 |
LRMR News
- 1 day ago - Larimar Therapeutics Announces Investor Event on the Nomlabofusp Program for Friedreich's Ataxia - GlobeNewsWire
- 4 weeks ago - Larimar Therapeutics initiated with an Overweight at JPMorgan - TheFly
- 5 weeks ago - Larimar Therapeutics price target lowered to $12 from $13 at Wedbush - TheFly
- 6 weeks ago - Larimar Therapeutics price target lowered to $12 from $13 at Wedbush - TheFly
- 6 weeks ago - Larimar Therapeutics reports Q1 EPS (31c), consensus (57c) - TheFly
- 6 weeks ago - Larimar Therapeutics Reports First Quarter 2026 Financial and Business Update - GlobeNewsWire
- 6 weeks ago - Larimar Therapeutics Earnings release: Q1 2026 - Filings
- 6 weeks ago - Larimar Therapeutics Quarterly report: Q1 2026 - Filings